Table 1 Patients and tumor characteristics of the high- and low-LCK-expression groups.
Characteristic | Total (n = 343) No. (%) | Low (n = 233) No. (%) | High (n = 110) No. (%) | p |
|---|---|---|---|---|
Age (years) | 0.743 | |||
< 59 | 178 (52) | 119 (51) | 59 (54) | |
≥ 60 | 165 (48) | 114 (49) | 51 (46) | |
Radiotherapy | 1 | |||
No | 321 (94) | 218 (94) | 103 (94) | |
Yes | 22 (6) | 15 (6) | 7 (6) | |
Chemotherapy | 0.793 | |||
No | 22 (6) | 16 (7) | 6 (5) | |
Yes | 321 (94) | 217 (93) | 104 (95) | |
Lymphatic invasion | 0.135 | |||
No | 40 (12) | 32 (14) | 8 (7) | |
Unknown | 210 (61) | 143 (61) | 67 (61) | |
Yes | 93 (27) | 58 (25) | 35 (32) | |
Venous invasion | 0.971 | |||
No | 32 (9) | 22 (9) | 10 (9) | |
Unknown | 251 (73) | 171 (73) | 80 (73) | |
Yes | 60 (17) | 40 (17) | 20 (18) | |
FIGO stage | 0.014 | |||
I/II | 19 (6) | 8 (3) | 11 (10) | |
III/IV | 321 (94) | 224 (96) | 97 (88) | |
Unknown | 3 (1) | 1 (0) | 2 (2) | |
Tumor residual disease | 0.572 | |||
No. Macroscopic disease | 58 (17) | 39 (17) | 19 (17) | |
1–10 mm | 162 (47) | 111 (48) | 51 (46) | |
Unknown | 36 (10) | 21 (9) | 15 (14) | |
≥ 10 mm | 87 (25) | 62 (27) | 25 (23) | |
Neoplasm histologic grade | 0.711 | |||
G1/G2 | 42 (12) | 31 (13) | 11 (10) | |
GX/unknown | 8 (2) | 6 (3) | 2 (2) | |
G3/G4 | 293 (85) | 196 (84) | 97 (88) |
